Position in INCY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$24,381,597
-$14,760,954 QoQ
Shares Held
259,048
-34.6% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $89,889,169 across 7 Biotechnology names. INCY ranks #2 (27.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
86,697 | $28,685,436 | |
| 2 | INCY |
Incyte Corp
This page
|
259,048 | $24,381,597 | |
| 3 | INSM |
INSMED Inc
|
77,970 | $12,749,654 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,903 | $10,673,645 | |
| 5 | RPRX |
Royalty Pharma plc
|
177,500 | $8,514,675 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,232 | $3,269,812 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
16,600 | $1,614,350 |
All Filings in INCY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,381,597 | 259,048 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $39,142,551 | 396,300 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $39,063,486 | 460,600 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $25,251,480 | 370,800 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $20,120,765 | 332,300 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $14,677,375 | 212,500 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $13,021,700 | 197,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $15,021,636 | 247,800 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $10,442,601 | 183,300 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $11,955,216 | 190,400 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $8,058,915 | 139,500 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,349,950 | 150,200 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,199,971 | 127,300 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,345,248 | 103,900 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,776,888 | 116,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,141,180 | 94,000 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $7,582,220 | 103,300 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $6,121,420 | 89,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,798,851 | 92,700 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,234,167 | 52,100 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,975,256 | 57,200 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,284,484 | 36,600 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,687,159 | 54,700 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $5,162,715 | 70,500 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||